or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    ACHL F Achilles Therapeutics plc -0.53
    ADAP D Adaptimmune Therapeutics plc -3.23
    AEG A AEGON N.V. 0.89
    ANIX F Anixa Biosciences, Inc. -0.68
    ATOS C Atossa Genetics Inc. 0.00
    AVBP C ArriVent BioPharma, Inc. 3.33
    BDTX D Black Diamond Therapeutics, Inc. -3.68
    BMY F Bristol-Myers Squibb Company -0.99
    BNOX F Bionomics Limited 0.30
    BYSI D BeyondSpring, Inc. 0.18
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Cancer Medicine Clinical Medicine Biopharmaceutical Biotechnology Immunotherapy Immune System Solid Tumors Virotherapy Cancer Immunotherapy Chimeric Antigen Receptor T Cell Hematological Malignancies Life Sciences Lymphocytes Natural Killer Cell Specialty Drugs Treatment Of Cancer Acid Acute Myeloid Leukemia Adoptive Cell Transfer

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    IDNA B iShares Genomics Immunology and Healthcare ETF 1.31
    CNCR D Loncar Cancer Immunotherapy ETF 1.12
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.82
    PTH C Invesco DWA Healthcare Momentum ETF 0.69
    AFSM B Active Factor Small Cap ETF 0.46
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare BBC to PTH Compare CNCR to AFSM Compare PTH to AFSM

        Cancer Treatment Stocks Recent News

        Date Stock Title
        May 16 AVBP ArriVent Appoints John Hohneker, M.D., to its Board of Directors
        May 16 BMY Walmart Earnings & the State of the Consumer
        May 16 AEG Aegon Ltd. (AEG) Q1 2024 Sales/ Trading Statement Call Transcript
        May 16 BMY Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
        May 16 BMY New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
        May 16 AEG 1Q 2024
        May 16 BMY Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
        May 16 BMY FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
        May 16 AEG Aegon gets new finance chief, gives Q1 trading update
        May 16 AEG Aegon Backs Guidance, Launches Fresh Buyback
        May 16 AEG Aegon appoints Duncan Russell to succeed Matt Rider as Chief Financial Officer
        May 16 AEG Aegon trading update for first quarter 2024
        May 16 BMY Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
        May 15 BMY Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript
        May 15 BMY Tudor Investment's top buys and sells in Q1
        May 15 BMY Bristol Myers' Breyanzi gains additional indication for follicular lymphoma
        May 15 BMY UPDATE 3-US FDA approves expanded use of Bristol Myers' cancer cell therapy
        May 15 ADAP Adaptimmune Therapeutics plc (ADAP) Q1 2024 Earnings Call Transcript
        May 15 ATOS Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
        May 15 ADAP Adaptimmune GAAP EPS of -$0.03 beats by $0.04, revenue of $5.7M misses by $11.37M
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Medicine Clinical Medicine Biopharmaceutical Biotechnology Immunotherapy Immune System Solid Tumors Virotherapy Cancer Immunotherapy Chimeric Antigen Receptor T Cell Hematological Malignancies Life Sciences Lymphocytes Natural Killer Cell Specialty Drugs Treatment Of Cancer Acid Acute Myeloid Leukemia Adoptive Cell Transfer
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags